Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells

Thomas Efferth, Marco Giaisi, Annette Merling et al. · 2007

Read Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells by Thomas Efferth, Marco Giaisi, Annette Merling et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0000693.txt.

Description

Thomas Efferth, Marco Giaisi, Annette Merling and colleagues tested a malaria drug against resistant leukemia cells, in PLOS ONE in 2007. Drug resistance is a major obstacle in cancer treatment, as tumor cells learn to survive chemotherapy. New drugs are urgently needed that hit tumor cells hard while sparing normal cells. Artesunate, a drug known from malaria care, was their candidate.

The title states their finding: artesunate triggers apoptosis, programmed cell death, in T leukemia cells that resist doxorubicin. The killing runs through ROS, reactive oxygen species that damage cells from inside. Repurposing a known drug for resistant cancers could shorten the road to the clinic.

Catalog record

CREATORThomas Efferth, Marco Giaisi, Annette Merling et al.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000693

Browse the full library · About the Tower of Babel